Extrastriatal dopaminergic changes in Parkinson's disease patients with impulse control disorders

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 85, Issue 1, 2014, Pages 23-30

  Lee, Jee Young ^a   Seo, Seong Ho ^a   Kim, Yu Kyeong ^a   Yoo, Hye Bin ^a   Kim, Young Eun ^b   Song, In Chan ^b   Lee, Jae Sung ^a   Jeon, Beom S ^b  

^a Seoul National University   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84891825785     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2013-305549     Document Type: Article

References (41)

1. Lee JY, Kim JM, Kim JW, et al. Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease. Parkinsonism Relat Disord 2010;16:202-7.
2. Weintraub D, Koester J, Potenza MN, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010;67:589-95.
3. Lim SY, Tan ZK, Ngam PI, et al. Impulsive-compulsive behaviors are common in Asian Parkinson's disease patients: assessment using the QUIP. Parkinsonism Relat Disord 2011;17:761-4.
4. Volkow ND, Fowler JS, Wang GJ, et al. Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol Psychiatry 2004;9:557-69. (Pubitemid 38850435)
5. Voon V, Pessiglione M, Brezing C, et al. Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors. Neuron 2010;65:135-42.
6. Voon V, Fox SH. Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol 2007;64:1089-96. (Pubitemid 47258066)
7. Ray N, Strafella AP. Dopamine, reward, and frontostriatal circuitry in impulse control disorders in Parkinson's disease: insights from functional imaging. Clin EEG Neurosci 2010;41:87-93.
8. Fiorillo CD, Tobler PN, Schultz W. Discrete coding of reward probability and uncertainty by dopamine neurons. Science 2003;299:1898-902. (Pubitemid 36356659)
9. Weintraub D, Siderowf AD, Potenza MN, et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 2006;63:969-73. (Pubitemid 44036299)
10. Mamikonyan E, Siderowf AD, Duda JE, et al. Long-term follow-up of impulse control disorders in Parkinson's disease. Mov Disord 2008;23:75-80. (Pubitemid 351281221)
11. Thobois S, Ardouin C, Lhommee E, et al. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation. Brain 2010;133:1111-27.
12. Voon V, Schoerling A, Wenzel S, et al. Frequency of impulse control behaviours associated with dopaminergic therapy in restless legs syndrome. BMC Neurol 2011;11:117.
13. O'Sullivan SS, Djamshidian A, Ahmed Z, et al. Impulsive-compulsive spectrum behaviors in pathologically confirmed progressive supranuclear palsy. Mov Disord 2010;25:638-42.
14. Holman AJ. Impulse control disorder behaviors associated with pramipexole used to treat fibromyalgia. J Gambl Stud 2009;3:425-31.
15. Cilia R, Cho SS, van Eimeren T, et al. Pathological gambling in patients with Parkinson's disease is associated with fronto-striatal disconnection: a path modeling analysis. Mov Disord 2011;26:225-33.
16. van Eimeren T, Pellecchia G, Cilia R, et al. Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD. Neurology 2010;75:1711-16.
17. Ouchi Y, Yoshikawa E, Okada H, et al. Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdale in early Parkinson's disease: compartment analysis for β-CFT binding with positron emission tomography. Ann Neurol 1999;45:601-10. (Pubitemid 29217588)
18. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-4.
19. Lee JY, Lee EK, Park SS, et al. Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson's disease. Mov Disord 2009;24:1803-10.
20. Collignon A, Vandermeulen D, Suetens P, et al. 3D multi-modality medical image registration using feature space clustering. In: Ayache N. ed CVRMed '95 proceedings of the first international conference on computer vision, virtual reality and robotics in medicine. London: Springer-Verlag, 1995:195-204.
21. Studholme C, Hill DLG, Hawkes DJ. Multiresolution voxel similarity measures for MR-PET registration. In: Bizais Y, Barillot C, Di Paola R. eds Proceedings of information processing in medical imaging. Dordrecht: Kluwer Academic Publishers, 1995:287-98.
22. Ashburner J, Friston KJ. Nonlinear spatial normalization using basis functions. Hum Brain Mapp 1999;7:254-66. (Pubitemid 29269964)
23. Lee JS, Lee DS. Analysis of functional brain images using population-based probabilistic Atlas. Curr Med Imaging Rev 2005;1:81-7.
24. Logan J, Fowler JS, Volkow ND, et al. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 1996;16:834-40. (Pubitemid 26292051)
25. Cilia R, Ko JH, Cho SS, et al. Reduced dopamine transporter density in the ventral striatum of patients with Parkinson's disease and pathological gambling. Neurobiol Dis 2010;39:98-104.
26. Steeves TD, Miyasaki J, Zurowski M, et al. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain 2009;132:1376-85.
27. Berridge KC. The debate over dopamine's role in reward: the case for incentive salience. Psychopharmacology (Berl) 2007;191:391-431. (Pubitemid 46355895)
28. Evans AH, Pavese N, Lawrence AD, et al. Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann Neurol 2006;59:852-8. (Pubitemid 43673163)
29. O'Sullivan SS, Wu K, Politis M, et al. Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours. Brain 2011;134:969-78.
30. Volkow ND, Wang GJ, Telang F, et al. Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci 2006;26: 6583-8. (Pubitemid 44318339)
31. Koob GF, Volkow ND. Neuropsychiatry of addiction. Neuropsychopharmacology 2010;35:217-38.
32. Lee CS, Samii A, Socci V, et al. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease. Ann Neurol 2000;47:493-503. (Pubitemid 30194606)
33. Haber SN, Knutson B. The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology 2010;35:4-26.
34. Joutsa J, Martikainen K, Niemelä S, et al. Increased medial orbitofrontal [18F] fluorodopa uptake in Parkinsonian impulse control disorders. Mov Disord 2012;27:778-82.
35. Goldstein RZ, Tomasi D, Rajaram S, et al. Role of the anterior cingulate and medial orbitofrontal cortex in processing drug cues in cocaine addiction. Neuroscience 2007;144:1153-9. (Pubitemid 46123821)
36. Hong LE, Gu H, Yang Y, et al. Nicotine addiction and nicotine's actions are associated with separate cingulate cortex functional circuits. Arch Gen Psychiatry 2009;66:431-41.
37. Godstein RZ, Craig AD, Bechara A, et al. The neurocircuitry of impaired insight in drug addiction. Trends Cogn Sci 2009;13:372-80.
38. Naqvi NH, Rudrauf D, Damasio H, et al. Damage to the insula disrupts addiction to cigarette smoking. Science 2007;315:531-4. (Pubitemid 46175760)
39. Smith KS, Tindell AJ, Aldridge JW, et al. Ventral pallidum roles in reward and motivation. Behav Brain Res 2009;196:155-67.
40. Obeso JA, Rodríguez-Oroz MC, Rodríguez M, et al. Pathophysiology of the basal ganglia in Parkinson's disease. Trends Neurosci 2000;23(10 Suppl):S8-19.
41. Whone AL, Moore RY, Piccini PP, et al. Plasticity of the nigropallidal pathway in Parkinson's disease. Ann Neurol 2003;53:206-13. (Pubitemid 36164002)